Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab…
Sandoz, a global leader in off-patent (generic and biosimilar) medicines, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Read More...
Read More...